Antibody Production Services Global Market Report 2025
상품코드:1889298
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
항체 생산 서비스 시장 규모는 최근 급속히 확대되고 있습니다. 2024년 57억 2,000만 달러로 평가되었고, 2025년에는 64억 4,000만 달러에 달할 것으로 추정되며, CAGR 12.6%로 성장할 전망입니다. 지난 수년간의 성장은 치료 개발에서 항체 이용 증가, 만성질환 및 자가면역 질환 유병률 상승, 맞춤형 의료 수요 증가, 생명공학 연구개발 활동 확대, 진단 용도에서의 단일클론 항체 채용 증가에 기인한 것으로 보입니다.
항체 생산 서비스 시장 규모는 향후 수년간 급속한 성장이 예상되고 있습니다. 2029년에는 102억 2,000만 달러에 달할 것으로 예측되며, CAGR 12.2%로 성장할 전망입니다. 예측 기간의 성장요인으로는 생명과학 연구에 대한 투자 증가, 학술기관 및 산업 연구기관 간 연계 강화, 생물제제 및 바이오시밀러 개발에 대한 주목 증가, 바이오의약품 혁신에 대한 정부 지원 확대 등이 있습니다. 예측 기간 중에 예상되는 주요 동향으로는 재조합 항체 생산 기술의 진보, 자동화 및 고성능 스크리닝 시스템 혁신, 항체 설계에 있어서 인공지능(AI) 및 머신러닝의 통합, 단일 B 세포 및 무세포 항체 생성 수법의 진전 등을 들 수 있습니다.
만성 질환의 유병률 상승은 향후 수년간 항체 생산 서비스 시장의 성장을 이끌 것으로 예측됩니다. 만성 질환은 점진적으로 진행되고 지속적인 의료 관리가 필요한 장기간의 건강 상태를 의미합니다. 이러한 질병 증가는 장기간의 앉기 및 운동 부족과 같은 불활성 생활 방식이 심장병이나 당뇨병 등의 위험을 높이는 데 일부 기인하고 있습니다. 항체 생산 서비스는 표적을 좁힌 치료 및 진단 솔루션을 제공하는 것으로 만성 질환의 관리를 지원해, 암, 자가면역 질환, 당뇨병 등의 병태에 있어서 매우 중요합니다. 이러한 서비스는 조기 발견, 모니터링 및 개인화 치료를 촉진하여 치료 정확도를 높이고 환자의 치료 성과와 질병 관리 전반의 효율성을 향상시킵니다. 예를 들어, 2024년 6월에 영국 국민보건서비스(NHS)가 발표한 데이터에 의하면, 2023년에 일반개업의(GP)에 등록되어 있는 361만 5,330명이 비당뇨병성 고혈당(당뇨병 예비군)이라고 진단되었습니다. 이는 2022년 306만 5,825건에서 18% 증가한 것으로 나타났습니다. 따라서 만성 질환의 유병률 증가는 항체 생산 서비스 시장의 확대를 뒷받침하고 있습니다.
항체 생산 서비스 시장의 주요 기업은 효율성 향상, 데이터 구동 인사이트 강화, 창약 프로세스 가속화를 위해 AI를 활용한 분석 등 고급 디지털 솔루션 개발에 주력하고 있습니다. AI를 활용한 분석에는 복잡한 생물학 및 화학적 데이터를 처리하여 결과를 예측하고, 패턴을 특정하며, 항체 등의 신규 치료법 설계를 생성하는 고도 계산 모델이 포함됩니다. 예를 들어, 2025년 8월에는 인도를 기반으로 한 과학 정보 서비스 제공업체인 Zifo가 Snowflake 마켓플레이스에서 'Zifo AI Engine for Antibody Engineering' 애플리케이션을 발표했습니다. 이 클라우드 네이티브 애플리케이션은 생성형 AI와 머신러닝 모델을 활용하여 항체 기반 치료를 신속하게 설계 및 최적화합니다. 예측 친화성 성숙화 및 인간화 기능을 갖추고 있어 대규모 사내 AI 인프라를 필요로 하지 않고 안전하고 확장 가능한 플랫폼에서 원활한 데이터 분석과 후보 창출을 가능하게 합니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향 및 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁 및 관세, 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석 및 전략 분석 프레임워크
세계의 항체 생산 서비스 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인 및 억제요인)
최종 이용 산업의 분석
세계의 항체 생산 서비스 시장 : 성장률 분석
세계의 항체 생산 서비스 시장 실적 : 규모 및 성장(2019-2024년)
세계의 항체 생산 서비스 시장 예측 : 규모 및 성장(2024-2029년, 2034년)
세계의 항체 생산 서비스 : 총 잠재 시장 규모(TAM)
제6장 시장 세분화
세계의 항체 생산 서비스 시장 : 유형별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
단일클론 항체
키메라 항체
인간화 항체
재조합 항체
폴리클로날 항체
세계의 항체 생산 서비스 시장 : 기술별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
하이브리도마 기술
파지 디스플레이 기술
효모 디스플레이 기술
세포 기반 기술
세계의 항체 생산 서비스 시장 : 용도별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
치료
연구
진단
세계의 항체 생산 서비스 시장 : 최종 사용자별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
제약 생명 공학 기업
학술 연구기관
병원 및 클리닉
수탁 연구기관
세계의 항체 생산 서비스 시장 : 단일클론 항체 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
인간 단일클론 항체
마우스 단일클론 항체
토끼 단일클론 항체
쥐 단일클론 항체
세계의 항체 생산 서비스 시장 : 키메라 항체 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
마우스 인간 키메라 항체
라토 인간 키메라 항체
토끼 인간 키메라 항체
영장류-인간 키메라 항체
세계의 항체 생산 서비스 시장 : 인간화 항체 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
상보성 결정 영역(CDR) 그래프트 항체
프레임워크 셔플 항체
재표면화된 인간화 항체
생식세포 계열 인간화 항체
세계의 항체 생산 서비스 시장 : 재조합 항체 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
싱글 체인 가변 영역 항체
항원 결합 단편 항체
이중특이성 재조합 항체
나노 바디
세계의 항체 생산 서비스 시장 : 폴리클로날 항체 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
토끼 폴리클로날 항체
염소 폴리클로날 항체
양 폴리클로날 항체
당나귀 폴리클로날 항체
제7장 지역별 및 국가별 분석
세계의 항체 생산 서비스 시장 : 지역별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
세계의 항체 생산 서비스 시장 : 국가별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도 및 기업 프로파일
항체 생산 서비스 시장 : 경쟁 구도
항체 생산 서비스 시장 : 기업 프로파일
Pfizer Inc.
AbbVie Inc.
Bayer AG
Novartis AG
Thermo Fisher Scientific Inc.
제31장 기타 주요 기업 및 혁신 기업
Merck KGaA
Danaher Corporation
Agilent Technologies Inc.
PerkinElmer Inc.
Sartorius AG
Bio-Rad Laboratories Inc.
Bio-Techne Corporation
Azenta Inc.
GenScript BIoTech Corporation
Invenra Inc.
Sino Biological Inc.
Proteintech Group Inc.
Rapid Novor
Rockland Immunochemicals Inc.
Biorbyt Ltd.
제32장 세계 시장 경쟁 벤치마킹 및 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문 및 전략
항체 생산 서비스 시장(2029년) : 새로운 기회를 제공하는 국가
항체 생산 서비스 시장(2029년) : 새로운 기회를 제공하는 부문
항체 생산 서비스 시장(2029년) : 성장 전략
시장 동향에 의한 전략
경쟁 전략
제36장 부록
AJY
영문 목차
영문목차
Antibody production services involve generating specific antibodies-either polyclonal or monoclonal-in response to target antigens. These services are widely used in research, diagnostic, and therapeutic applications to support the detection, measurement, or neutralization of particular proteins or pathogens. They provide high-quality, validated antibodies that advance biomedical research and drug development.
The primary types of antibody production services include monoclonal antibodies, chimeric antibodies, humanized antibodies, recombinant antibodies, and polyclonal antibodies. Monoclonal antibodies are laboratory-produced molecules designed to bind to a single epitope on an antigen, offering high precision and consistency in research, diagnostic, and therapeutic settings. These services rely on technologies such as hybridoma technology, phage display, yeast display, and cell-based platforms. Key applications include therapeutic, research, and diagnostic uses, and they serve end-users such as pharmaceutical and biotechnology companies, academic and research institutions, hospitals and clinics, and contract research organizations.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.
The antibody production services market research report is one of a series of new reports from The Business Research Company that provides antibody production services market statistics, including the antibody production services industry global market size, regional shares, competitors with the antibody production services market share, detailed antibody production services market segments, market trends, and opportunities, and any further data you may need to thrive in the antibody production services industry. This antibody production services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The antibody production services market size has grown rapidly in recent years. It will grow from $5.72 billion in 2024 to $6.44 billion in 2025 at a compound annual growth rate (CAGR) of 12.6%. Growth in the historic period can be attributed to the increasing use of antibodies in therapeutic drug development, the rising prevalence of chronic and autoimmune diseases, growing demand for personalized medicine, expanding biotechnology research and development activities, and the rising adoption of monoclonal antibodies in diagnostic applications.
The antibody production services market size is expected to see rapid growth in the next few years. It will grow to $10.22 billion in 2029 at a compound annual growth rate (CAGR) of 12.2%. Growth in the forecast period can be attributed to increasing investment in life sciences research, greater collaboration between academic and industrial research institutions, a rising focus on biologics and biosimilars development, and expanding government support for biopharmaceutical innovation. Major trends expected in the forecast period include advancements in recombinant antibody production technologies, innovations in automation and high-throughput screening systems, the integration of artificial intelligence and machine learning in antibody design, and progress in single B-cell and cell-free antibody generation methods.
The rising prevalence of chronic diseases is expected to drive the growth of the antibody production services market in the coming years. Chronic diseases are long-lasting health conditions that develop gradually and often require ongoing medical care. The increasing prevalence of these diseases is partly due to inactive lifestyles, where prolonged sitting and minimal physical activity elevate the risk of conditions like heart disease and diabetes. Antibody production services support chronic disease management by offering targeted therapeutic and diagnostic solutions, making them critical for conditions such as cancer, autoimmune disorders, and diabetes. These services improve treatment accuracy by facilitating early detection, monitoring, and personalized therapies, thereby enhancing patient outcomes and overall disease management efficiency. For example, in June 2024, the National Health Service (NHS) in the UK reported that 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia (pre-diabetes) in 2023, representing an 18% increase from 3,065,825 cases in 2022. As such, the growing prevalence of chronic diseases is fueling the expansion of the antibody production services market.
Leading companies in the antibody production services market are focusing on the development of advanced digital solutions, such as AI-powered analytics, to improve efficiency, enhance data-driven insights, and accelerate discovery timelines. AI-powered analytics involve advanced computational models that process complex biological and chemical data to predict outcomes, identify patterns, and generate novel therapeutic designs, such as for antibodies. For instance, in August 2025, Zifo, an India-based provider of scientific informatics services, introduced the Zifo AI Engine for Antibody Engineering application on the Snowflake Marketplace. This cloud-native application leverages generative AI and machine learning models to quickly design and optimize antibody-based therapeutics. It includes predictive affinity maturation and humanization features, allowing for seamless data analysis and candidate generation on a secure, scalable platform without the need for extensive internal AI infrastructure.
In March 2024, Sino Biological Inc., a China-based biotechnology company, partnered with Rapid Novor Inc., a Canada-based biotechnology company specializing in protein and antibody sequencing technologies. This collaboration aims to enhance Sino Biological's custom monoclonal antibody development and production services by integrating Rapid Novor's REmAb sequencing technology. The partnership allows clients to access both precise antibody sequence data and purified bioactive antibodies, thus improving research efficiency.
Major companies operating in the antibody production services market are Pfizer Inc., AbbVie Inc., Bayer AG, Novartis AG, Thermo Fisher Scientific Inc., Merck KGaA, Danaher Corporation, Agilent Technologies Inc., PerkinElmer Inc., Sartorius AG, Bio-Rad Laboratories Inc., Bio-Techne Corporation, Azenta Inc., GenScript Biotech Corporation, Invenra Inc., Sino Biological Inc., Proteintech Group Inc., Rapid Novor, Rockland Immunochemicals Inc., Biorbyt Ltd.
North America was the largest region in the antibody production services market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in antibody production services report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the antibody production services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The antibody production services market includes revenues earned by entities through antigen design, immunization, hybridoma development, antibody purification, characterization, and antibody labeling and conjugation. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Antibody Production Services Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on antibody production services market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for antibody production services ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The antibody production services market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
3) By Humanized Antibodies: Complementarity Determining Region Grafted Antibodies; Framework Shuffling Antibodies; Resurfaced Humanized Antibodies; Germline Humanized Antibodies
4) By Recombinant Antibodies: Single Chain Variable Fragment Antibodies; Fragment Antigen Binding Antibodies; Bispecific Recombinant Antibodies; Nanobodies
2. Antibody Production Services Market Characteristics
3. Antibody Production Services Market Trends And Strategies
4. Antibody Production Services Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Antibody Production Services Growth Analysis And Strategic Analysis Framework
5.1. Global Antibody Production Services PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Antibody Production Services Market Growth Rate Analysis
5.4. Global Antibody Production Services Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Antibody Production Services Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Antibody Production Services Total Addressable Market (TAM)
6. Antibody Production Services Market Segmentation
6.1. Global Antibody Production Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Monoclonal Antibodies
Chimeric Antibodies
Humanized Antibodies
Recombinant Antibodies
Polyclonal Antibodies
6.2. Global Antibody Production Services Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hybridoma Technology
Phage Display Technology
Yeast Display Technology
Cell-Based Technology
6.3. Global Antibody Production Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Therapeutic
Research
Diagnostic
6.4. Global Antibody Production Services Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pharmaceutical and Biotechnology Companies
Academic and Research Institutes
Hospitals and Clinics
Contract Research Organizations
6.5. Global Antibody Production Services Market, Sub-Segmentation Of Monoclonal Antibodies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Human Monoclonal Antibodies
Mouse Monoclonal Antibodies
Rabbit Monoclonal Antibodies
Rat Monoclonal Antibodies
6.6. Global Antibody Production Services Market, Sub-Segmentation Of Chimeric Antibodies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Mouse-Human Chimeric Antibodies
Rat-Human Chimeric Antibodies
Rabbit-Human Chimeric Antibodies
Primate-Human Chimeric Antibodies
6.7. Global Antibody Production Services Market, Sub-Segmentation Of Humanized Antibodies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Complementarity Determining Region Grafted Antibodies
Framework Shuffling Antibodies
Resurfaced Humanized Antibodies
Germline Humanized Antibodies
6.8. Global Antibody Production Services Market, Sub-Segmentation Of Recombinant Antibodies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Single Chain Variable Fragment Antibodies
Fragment Antigen Binding Antibodies
Bispecific Recombinant Antibodies
Nanobodies
6.9. Global Antibody Production Services Market, Sub-Segmentation Of Polyclonal Antibodies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Rabbit Polyclonal Antibodies
Goat Polyclonal Antibodies
Sheep Polyclonal Antibodies
Donkey Polyclonal Antibodies
7. Antibody Production Services Market Regional And Country Analysis
7.1. Global Antibody Production Services Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Antibody Production Services Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Antibody Production Services Market
8.1. Asia-Pacific Antibody Production Services Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Antibody Production Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Antibody Production Services Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Antibody Production Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Antibody Production Services Market
9.1. China Antibody Production Services Market Overview
9.2. China Antibody Production Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Antibody Production Services Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Antibody Production Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Antibody Production Services Market
10.1. India Antibody Production Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Antibody Production Services Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Antibody Production Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Antibody Production Services Market
11.1. Japan Antibody Production Services Market Overview
11.2. Japan Antibody Production Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Antibody Production Services Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Antibody Production Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Antibody Production Services Market
12.1. Australia Antibody Production Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Antibody Production Services Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Antibody Production Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Antibody Production Services Market
13.1. Indonesia Antibody Production Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Antibody Production Services Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Antibody Production Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Antibody Production Services Market
14.1. South Korea Antibody Production Services Market Overview
14.2. South Korea Antibody Production Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Antibody Production Services Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Antibody Production Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Antibody Production Services Market
15.1. Western Europe Antibody Production Services Market Overview
15.2. Western Europe Antibody Production Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Antibody Production Services Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Antibody Production Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Antibody Production Services Market
16.1. UK Antibody Production Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Antibody Production Services Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Antibody Production Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Antibody Production Services Market
17.1. Germany Antibody Production Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Antibody Production Services Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Antibody Production Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Antibody Production Services Market
18.1. France Antibody Production Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Antibody Production Services Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Antibody Production Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Antibody Production Services Market
19.1. Italy Antibody Production Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Antibody Production Services Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Antibody Production Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Antibody Production Services Market
20.1. Spain Antibody Production Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Antibody Production Services Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Antibody Production Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Antibody Production Services Market
21.1. Eastern Europe Antibody Production Services Market Overview
21.2. Eastern Europe Antibody Production Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Antibody Production Services Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Antibody Production Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Antibody Production Services Market
22.1. Russia Antibody Production Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Antibody Production Services Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Antibody Production Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Antibody Production Services Market
23.1. North America Antibody Production Services Market Overview
23.2. North America Antibody Production Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Antibody Production Services Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Antibody Production Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Antibody Production Services Market
24.1. USA Antibody Production Services Market Overview
24.2. USA Antibody Production Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Antibody Production Services Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Antibody Production Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Antibody Production Services Market
25.1. Canada Antibody Production Services Market Overview
25.2. Canada Antibody Production Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Antibody Production Services Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Antibody Production Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Antibody Production Services Market
26.1. South America Antibody Production Services Market Overview
26.2. South America Antibody Production Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Antibody Production Services Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Antibody Production Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Antibody Production Services Market
27.1. Brazil Antibody Production Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Antibody Production Services Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Antibody Production Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Antibody Production Services Market
28.1. Middle East Antibody Production Services Market Overview
28.2. Middle East Antibody Production Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Antibody Production Services Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Antibody Production Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Antibody Production Services Market
29.1. Africa Antibody Production Services Market Overview
29.2. Africa Antibody Production Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Antibody Production Services Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Antibody Production Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Antibody Production Services Market Competitive Landscape And Company Profiles
30.1. Antibody Production Services Market Competitive Landscape
30.2. Antibody Production Services Market Company Profiles
30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.2. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
31. Antibody Production Services Market Other Major And Innovative Companies
31.1. Merck KGaA
31.2. Danaher Corporation
31.3. Agilent Technologies Inc.
31.4. PerkinElmer Inc.
31.5. Sartorius AG
31.6. Bio-Rad Laboratories Inc.
31.7. Bio-Techne Corporation
31.8. Azenta Inc.
31.9. GenScript Biotech Corporation
31.10. Invenra Inc.
31.11. Sino Biological Inc.
31.12. Proteintech Group Inc.
31.13. Rapid Novor
31.14. Rockland Immunochemicals Inc.
31.15. Biorbyt Ltd.
32. Global Antibody Production Services Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Antibody Production Services Market
34. Recent Developments In The Antibody Production Services Market
35. Antibody Production Services Market High Potential Countries, Segments and Strategies
35.1 Antibody Production Services Market In 2029 - Countries Offering Most New Opportunities
35.2 Antibody Production Services Market In 2029 - Segments Offering Most New Opportunities
35.3 Antibody Production Services Market In 2029 - Growth Strategies
